CBI court discharges former joint drugs controller in 2022 Biocon bribery base
A special CBI court discharged Dr S. Eswara Reddy and three others, ruling that the agency failed to provide evidence of a bribe demand or criminal conspiracy to establish a prima facie case.
The CBI court discharged former joint drugs controller Dr. S. Eswara Reddy and three others in a 2022 bribery case linked to Biocon Biologics Ltd. The court found that the allegations against Reddy failed to establish a prima facie case, as there was no direct or circumstantial evidence of a bribe demand. The court ruled that Reddy was entitled to be discharged from the case, noting that the prosecution had not met the mandatory requirement for proving the offence.
The court also dismissed allegations of criminal conspiracy and found insufficient material to establish that Reddy had improperly performed his official duties.
Brief written by urgent.news from Live Mint's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
